Celemics Decides on 1,384,578 Share Third-Party Allotment Capital Increase, Raising Concerns over ~14% Dilution and Uncertain Use of Funds Threatening Shareholder Value
Celemics announced a third-party allotment capital increase of 1,384,578 new shares via board resolution on March 31, 2026, and corrected the listing date to July 16, 2026.
The issuance price of 8,378 KRW represents a 10% discount to the reference price of 9,308 KRW, and the approximately 11.6 billion KRW raised will be used entirely for acquiring securities of other corporations, though the specific counterparty and target remain undecided.
This capital increase dilutes existing shareholders by approximately 14.13%, and although the new shares are subject to a one-year lock-up, the large dilution and uncertainty in fund execution are expected to negatively impact short-term stock price.
The allottees include Supigen New Technology Investment Association No.1 and individual investors, including two unregistered executives, raising governance concerns regarding minority shareholder protection.
[AI Summary]Celemics diluted existing shareholders by 14% to raise approximately 11.6 billion KRW, with the use of funds for acquiring securities of other corporations remaining vague, increasing investment risk. Insider participation adds governance risks, and short-term stock price pressure is anticipated.
KOSDAQ Filing Information
[Correction of Description] Report on Major Events (Decision on Paid-in Capital Increase)